No Detail Found!

Migraine Persistence Among University Students - A Case Study of SMBBMU Larkana.

Author(s)
Tahseen Ahmed Department of Pharmacognosy, Faculty of Pharmacy, Zia-ud-din University, Karachi, Pakistan
Ambreen Huma Department of Pharmacognosy, Faculty of Pharmacy, Zia-ud-din University, Karachi, Pakistan
Waqar Ahmed Department of Pharmaceutics, Faculty of Pharmacy, University of Sindh, Jamshoro, Pakistan
Nadeem Balouch Department of Pharmacy, Shaheed Mohtarma Benazir Bhutto Medical University (SMBBMU), Larkana, Pakistan
Waseem Malhani Department of Pharmacy, Shaheed Mohtarma Benazir Bhutto Medical University (SMBBMU), Larkana, Pakistan
Abstract
Purpose: The theme of this research is to assess the persistence of migraine among students of SMBB Medical University, Larkana. Methodology: The descriptive cross-sectional study was carried out at Shaheed Mohtarma Benazir Bhutto Medical University (SMBBMU) Larkana for the duration of 7.3 months from 6th of May 2017 to 9th of December 2017 and migraine persistence was assessed among medical students. A questionnaire was given to them to evaluate the severity of migraine. Students with severe head injury or any other medical complications was excluded were not included in this research. Results: A contributive sampling techniques was used to collect the data for analysis. Total 213 study subjects had participated in this research including 137 male students and 76 female students. Specific measuring tool was used to identify the severity of migraine with mild, moderate and severe were used as parameters for identification of severity. Conclusion: Frequency of headache was observed more in feminine gender as compared to male Students. Females were more conscious about life styles and they always had emotional attachment with every event of their life including results, class presentation and dressing or university functions.
Publication Details
Page(s) 254-258
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 6, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
severity, Persistence, feminine
References
DelfanB,BahmaniM,HassanzadazarH,SakiK,Rafieian-KopaeiM, 2014.Identification of medicinal plants affecting on headaches and migraines in Lorestan Province, West of Iran,Asian Pac J Trop Med 7 S376 -9
BalarabeS,YunusaMA, 2016.Prevalence of migraine among medical students in Sokoto, North-Western Nigeria,Eur J Pharm Med Res 3 604 -8
MorilloLE,AlarconF,AranagaN,AuletS,ChapmanE,ConternoL, 2005.Prevalence of migraine in Latin America,Headache 45 106 -17
BigalME,LiptonRB, 2006.Modifiable risk factors for migraine progression,Headache 46 1334 -43
PasschierJ,De BooM,QuaakHZ,BrienenJA, 1996.Health-related quality of life of chronic headache patients is predicted by the emotional component of their pain,Headache 36 556 -60
NaegelS,HolleD,DesmarattesN,TheysohnN,DienerHC,KatsaravaZ, 2014.Cortical plasticity in episodic and chronic cluster headache,Neuroimage Clin 6 415 -23
NesbittAD,MarinJCA,TompkinsE,RuttledgeMH,GoadsbyPJ, .Initial use of a novel noninvasive, -
SilbersteinSD,CalhounAH,LiptonRB,GrosbergBM,CadyRK,DorlasS, 2016.Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study,Neurology 87 529 -38
HeadacheClassification, 2013.Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version),Cephalalgia 33 629 -808
Al-HashelJY,AhmedSF,AlroughaniR,GoadsbyPJ, 2014.Migraine among medical students in Kuwait University,J Headache Pain 15 26 -
Tfelt-HansenP,PascualJ,RamadanN,DahlöfC,D'AmicoD,DienerHC, 2012.Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators,Cephalalgia 32 6 -38
TepperS,AshinaM,ReuterU,BrandesJL,DoležilD,SilbersteinS, 2017.Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebocontrolled phase 2 trial,Lancet Neurol 16 425 -34
2004.Headache Classification Subcommittee of the International Headache Society,The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 9 -160
HansenJM,ThomsenLL,OlesenJ,AshinaM., 2008.Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype,Neurology 71 841 -7
NorrisS,AtkinsD,BrueningW, 2010.Selecting observational studies for comparing medical interventions,In: Agency for Healthcare Research and Quality. Methods Guide for Comparative Effectiveness Reviews [posted June -
HigginsJ,GreenS, 2011.,Cochrane handbook for systematic reviews of interventions. Version 5.1.0 -
ChouR,AronsonN,AtkinsD,IsmailaAS,SantaguidaP,SmithDH, 2010.AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program,J Clin Epidemiol 63 502 -12
HigginsJP,AltmanDG,GøtzschePC,JüniP,MoherD,OxmanAD, 2011.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials,BMJ 343 d5928 -
van der VeldeG,van TulderM,CôtéP,HoggJohnsonS,AkerP,CassidyJD, 2007.The sensitivity of review results to methods used to appraise and incorporate trial quality into data synthesis,Spine (Phila Pa 32 796 -806
HerbisonP,Hay-SmithJ,GillespieWJ, 2006.Adjustment of meta-analyses on the basis of quality scores should be abandoned,J Clin Epidemiol 59 1249 -56
Ad, 1962.Hoc Committee on Classification of Headache. Classification of headache,JAMA 179 717 -8
TreadwellJR,UhlS,TiptonK,ShamliyanT,ViswanathanM,BerkmanND, 2012.Assessing equivalence and noninferiority,J Clin Epidemiol 65 1144 -9
0

Citations

0

Downloads

73

Views